Mergers and Acquisitions (M&A) market activities are often complex and overwhelming for emerging firms in the Life Sciences sector.

To maximize the impact of a growth strategy, M&A activities must be successfully managed. Katan provides management teams around the world with access to specialized knowledge on the buy and sell side of any Life Sciences business transaction.

Katan specializes is assisting companies with less than US $50 million in revenue, with particular emphasis on the therapeutics, diagnostics, device, and lab supply/reagents segments of the Life Sciences sector.

Katan has been successful in the facilitation of several transactions in each of these segments, responsibilities which have stretched from concept to close.

Katan focuses on deal structuring and packaging. Katan is able to guide business owners and managers through each step of the financing process, including acquisition, trade sale or merger.

Katan's skill set for client companies include:

• The creation of process objectives and the forecasting of strategic implications
• Market analysis for the identification of targets, buyers, and sellers
• Development and preparation of documentation
• Financial analysis
• Business valuations
• Due diligence, working closely with the client's other professional advisors (such as accountants, lawyers and other specialist advisors)
• Deal structuring, packaging, and negotiation
• Term sheet structuring and negotiation
• Negotiation participation and assistance to lawyers in drafting documents to encompass the financial and operational terms won in negotiation, through to deal closing.